ASSET (Age/Sex Standardised Estimates of Treatment): A research model to improve the governance of prescribing funds in Italy

Giampiero Favato, Paolo Mariani, Roger W. Mills, Alessandro Capone, Matteo Pelagatti, Vasco Pieri, Alberico Marcobelli, Maria G. Trotta, Alberto Zucchi, Alberico L. Catapano

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Backround. The primary objective of this study was to make the first step in the modelling of pharmaceutical demand in Italy, by deriving a weighted capitation model to account for demographic differences among general practices. The experimental model was called ASSET (Age/Sex Standardised Estimates of Treatment). Methods and Major Findings. Individual prescription costs and demographic data referred to 3,175,691 Italian subjects and were collected directly from three Regional Health Authorities over the 12-month period between October 2004 and September 2005. The mean annual prescription cost per individual was similar for males (196.13 euro) and females (195.12 euro). After 65 years of age, the mean prescribing costs for males were significantly higher than females. On average, costs for a 75-year-old subject would be 12 times the costs for a 25-34 year-old subject if male, 8 times if female. Subjects over 65 years of age (22% of total population) accounted for 56% of total prescribing costs. The weightings explained approximately 90% of the evolution of total prescribing costs, in spite of the pricing and reimbursement turbulences affecting Italy in the 2000-2005 period. The ASSET weightings were able to explain only about 25% of the variation in prescribing costs among individuals. Conclusions. If mainly idiosyncratic prescribing by general practitioners causes the unexplained variations, the introduction of capitation-based budgets would gradually move practices with high prescribing costs towards the national average. It is also possible, though, that the unexplained individual variation in prescribing costs is the result of differences in the clinical characteristics or socio-economic conditions of practice populations. If this is the case, capitation-based budgets may lead to unfair distribution of resources. The ASSET age/sex weightings should be used as aguide, not as the ultimate determinant, for an equitable allocation of prescribing resources to regional authorities and general practices.

Original languageEnglish
Article numbere592
JournalPLoS One
Volume2
Issue number7
DOIs
Publication statusPublished - Jul 4 2007

Fingerprint

Financial Management
governance
Italy
Costs and Cost Analysis
gender
Research
Costs
Therapeutics
demographic statistics
general practitioners
Budgets
resource allocation
General Practice
Prescriptions
socioeconomics
Demography
Resource Allocation
drugs
General Practitioners
Population

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

ASSET (Age/Sex Standardised Estimates of Treatment) : A research model to improve the governance of prescribing funds in Italy. / Favato, Giampiero; Mariani, Paolo; Mills, Roger W.; Capone, Alessandro; Pelagatti, Matteo; Pieri, Vasco; Marcobelli, Alberico; Trotta, Maria G.; Zucchi, Alberto; Catapano, Alberico L.

In: PLoS One, Vol. 2, No. 7, e592, 04.07.2007.

Research output: Contribution to journalArticle

Favato, G, Mariani, P, Mills, RW, Capone, A, Pelagatti, M, Pieri, V, Marcobelli, A, Trotta, MG, Zucchi, A & Catapano, AL 2007, 'ASSET (Age/Sex Standardised Estimates of Treatment): A research model to improve the governance of prescribing funds in Italy', PLoS One, vol. 2, no. 7, e592. https://doi.org/10.1371/journal.pone.0000592
Favato, Giampiero ; Mariani, Paolo ; Mills, Roger W. ; Capone, Alessandro ; Pelagatti, Matteo ; Pieri, Vasco ; Marcobelli, Alberico ; Trotta, Maria G. ; Zucchi, Alberto ; Catapano, Alberico L. / ASSET (Age/Sex Standardised Estimates of Treatment) : A research model to improve the governance of prescribing funds in Italy. In: PLoS One. 2007 ; Vol. 2, No. 7.
@article{b92734cff1e94794bf12a40e79f12d45,
title = "ASSET (Age/Sex Standardised Estimates of Treatment): A research model to improve the governance of prescribing funds in Italy",
abstract = "Backround. The primary objective of this study was to make the first step in the modelling of pharmaceutical demand in Italy, by deriving a weighted capitation model to account for demographic differences among general practices. The experimental model was called ASSET (Age/Sex Standardised Estimates of Treatment). Methods and Major Findings. Individual prescription costs and demographic data referred to 3,175,691 Italian subjects and were collected directly from three Regional Health Authorities over the 12-month period between October 2004 and September 2005. The mean annual prescription cost per individual was similar for males (196.13 euro) and females (195.12 euro). After 65 years of age, the mean prescribing costs for males were significantly higher than females. On average, costs for a 75-year-old subject would be 12 times the costs for a 25-34 year-old subject if male, 8 times if female. Subjects over 65 years of age (22{\%} of total population) accounted for 56{\%} of total prescribing costs. The weightings explained approximately 90{\%} of the evolution of total prescribing costs, in spite of the pricing and reimbursement turbulences affecting Italy in the 2000-2005 period. The ASSET weightings were able to explain only about 25{\%} of the variation in prescribing costs among individuals. Conclusions. If mainly idiosyncratic prescribing by general practitioners causes the unexplained variations, the introduction of capitation-based budgets would gradually move practices with high prescribing costs towards the national average. It is also possible, though, that the unexplained individual variation in prescribing costs is the result of differences in the clinical characteristics or socio-economic conditions of practice populations. If this is the case, capitation-based budgets may lead to unfair distribution of resources. The ASSET age/sex weightings should be used as aguide, not as the ultimate determinant, for an equitable allocation of prescribing resources to regional authorities and general practices.",
author = "Giampiero Favato and Paolo Mariani and Mills, {Roger W.} and Alessandro Capone and Matteo Pelagatti and Vasco Pieri and Alberico Marcobelli and Trotta, {Maria G.} and Alberto Zucchi and Catapano, {Alberico L.}",
year = "2007",
month = "7",
day = "4",
doi = "10.1371/journal.pone.0000592",
language = "English",
volume = "2",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "7",

}

TY - JOUR

T1 - ASSET (Age/Sex Standardised Estimates of Treatment)

T2 - A research model to improve the governance of prescribing funds in Italy

AU - Favato, Giampiero

AU - Mariani, Paolo

AU - Mills, Roger W.

AU - Capone, Alessandro

AU - Pelagatti, Matteo

AU - Pieri, Vasco

AU - Marcobelli, Alberico

AU - Trotta, Maria G.

AU - Zucchi, Alberto

AU - Catapano, Alberico L.

PY - 2007/7/4

Y1 - 2007/7/4

N2 - Backround. The primary objective of this study was to make the first step in the modelling of pharmaceutical demand in Italy, by deriving a weighted capitation model to account for demographic differences among general practices. The experimental model was called ASSET (Age/Sex Standardised Estimates of Treatment). Methods and Major Findings. Individual prescription costs and demographic data referred to 3,175,691 Italian subjects and were collected directly from three Regional Health Authorities over the 12-month period between October 2004 and September 2005. The mean annual prescription cost per individual was similar for males (196.13 euro) and females (195.12 euro). After 65 years of age, the mean prescribing costs for males were significantly higher than females. On average, costs for a 75-year-old subject would be 12 times the costs for a 25-34 year-old subject if male, 8 times if female. Subjects over 65 years of age (22% of total population) accounted for 56% of total prescribing costs. The weightings explained approximately 90% of the evolution of total prescribing costs, in spite of the pricing and reimbursement turbulences affecting Italy in the 2000-2005 period. The ASSET weightings were able to explain only about 25% of the variation in prescribing costs among individuals. Conclusions. If mainly idiosyncratic prescribing by general practitioners causes the unexplained variations, the introduction of capitation-based budgets would gradually move practices with high prescribing costs towards the national average. It is also possible, though, that the unexplained individual variation in prescribing costs is the result of differences in the clinical characteristics or socio-economic conditions of practice populations. If this is the case, capitation-based budgets may lead to unfair distribution of resources. The ASSET age/sex weightings should be used as aguide, not as the ultimate determinant, for an equitable allocation of prescribing resources to regional authorities and general practices.

AB - Backround. The primary objective of this study was to make the first step in the modelling of pharmaceutical demand in Italy, by deriving a weighted capitation model to account for demographic differences among general practices. The experimental model was called ASSET (Age/Sex Standardised Estimates of Treatment). Methods and Major Findings. Individual prescription costs and demographic data referred to 3,175,691 Italian subjects and were collected directly from three Regional Health Authorities over the 12-month period between October 2004 and September 2005. The mean annual prescription cost per individual was similar for males (196.13 euro) and females (195.12 euro). After 65 years of age, the mean prescribing costs for males were significantly higher than females. On average, costs for a 75-year-old subject would be 12 times the costs for a 25-34 year-old subject if male, 8 times if female. Subjects over 65 years of age (22% of total population) accounted for 56% of total prescribing costs. The weightings explained approximately 90% of the evolution of total prescribing costs, in spite of the pricing and reimbursement turbulences affecting Italy in the 2000-2005 period. The ASSET weightings were able to explain only about 25% of the variation in prescribing costs among individuals. Conclusions. If mainly idiosyncratic prescribing by general practitioners causes the unexplained variations, the introduction of capitation-based budgets would gradually move practices with high prescribing costs towards the national average. It is also possible, though, that the unexplained individual variation in prescribing costs is the result of differences in the clinical characteristics or socio-economic conditions of practice populations. If this is the case, capitation-based budgets may lead to unfair distribution of resources. The ASSET age/sex weightings should be used as aguide, not as the ultimate determinant, for an equitable allocation of prescribing resources to regional authorities and general practices.

UR - http://www.scopus.com/inward/record.url?scp=39449088174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39449088174&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0000592

DO - 10.1371/journal.pone.0000592

M3 - Article

C2 - 17611624

AN - SCOPUS:39449088174

VL - 2

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 7

M1 - e592

ER -